14.1 T whole body MRI for detection of mesoangioblast stem cells in a murine model of duchenne muscular dystrophy

Magnetic Resonance in Medicine

Volumn 66, Issue 6, 2011, Pages 1704-1714

  Odintsov, Boris ^a   Chun, Ju Lan ^a   Mulligan, James A ^a   Berry, Suzanne E ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Duchenne; mesoangioblast; MRI; SPIO

Indexed keywords

CYTOLOGY; IRON OXIDES; MAGNETIC NANOPARTICLES; MAGNETIC RESONANCE IMAGING; MAMMALS; MOLECULAR BIOLOGY; STEM CELLS; SUPERPARAMAGNETISM;

ACTIVATED MACROPHAGES; DUCHENNE; DUCHENNE MUSCULAR DYSTROPHIES; INTRACARDIAC INJECTION; MESOANGIOBLAST; SPIO; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDES;

MUSCLE;

DYSTROPHIN; FERRIC FERROCYANIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HEART MUSCLE; HEMANGIOBLAST; IN VIVO STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIOFREQUENCY; SKELETAL MUSCLE; STEM CELL; WHOLE BODY MRI;

EID: 81355147467     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22942     Document Type: Article

References (35)

1. Emery AE,. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1991; 1: 19-29.
2. Guglieri M, Bushby K,. Molecular treatments in Duchenne muscular dystrophy. Curr Opin Pharmacol 2010; 10: 1-7.
3. Mendell JR, Rodino-Klapac LR, Malik V,. Molecular therapeutic strategies targeting Duchenne muscular dystrophy. J. Child Neurol. 2010; 25: 1145-1148.
4. Berry SE, Liu J, Chaney EJ, Kaufman SJ,. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy. Regen Med 2007; 2: 275-288.
5. Sampaolesi M, Torrent Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino MA, Barresi R, Bresolin N, De Angelis MG, Campbell KP, Bottinelli, R, Cossu G,. Cell therapy of α-sarcoglycan-null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301: 487-492.
6. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A, Mognol P, Thibaud JL, Galvez BG, Barthélémy I, Perani L, Mantero S, Guttinger M, Pansarasa O, Rinaldi C, Cusella De Angelis MG, Torrente Y, Bordignon C, Bottinelli R, Cossu G,. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006; 444: 574-579.
7. Stroh A, Faber C, Neuberger T, Lorenz P, Sieland K, Jakob PM, Webb A, Pilgrimm H, Schober R, Pohl EE, Zimmer C,. In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17.6T) magnetic resonance imaging. NeuroImage 2005; 24: 635-645.
8. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, Capela A, Greve J, Malenka RC, Moseley ME, Palmer TD, Steinberg GK,. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci USA 2007; 104: 10211-10216.
9. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabells J, Young RG, Pittenger MF, van Zijl PCF, Huang J, Bulte JWM,. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008; 39: 1569-1574.
10. Sykova E, Jendelová P, Herynek, V,. MR tracking of stem cells in living recipients. Meth Mol Biol Neural Cell Transpl 2009: 549; 197-215.
11. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA,. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cerebral Blood Flow Metab 2010; 30: 15-35.
12. Cahill KS, Gaidosh G, Huard J, Silver X, Byrne BJ, Walter GA,. Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation 2004; 78: 1626-1633.
13. Odintsov BM,. Tunable radiofrequency coil. US Patent US 2010/10013483 A1; 2010.
14. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW,. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004; 17: 513-517.
15. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF,. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 2004; 104: 3410-3412.
16. Henning TD, Sutton EJ, Kim A, Golovko D, Horvai A, Ackerman L, Sennino B, McDonald D, Lotz J, Daldrup-Link HE,. The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol Imaging 2009; 4: 165-173.
17. Yang CY, Hsiao JK, Tai MF, Chen ST, Cheng HY, Wang JL, Liu HM,. Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution. Mol Imaging Biol 2011; 13: 443-451.
18. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA,. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 2005; 18: 383-389.
19. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA,. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846.
20. Mailänder V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H,. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 2008; 10: 138-146.
21. Lorenz MR, Holzapfel V, Musyanovych A, Nothelfer K, Walther P, Frank H, Landfester K, Schrezenmeier H, Mailänder V,. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 2006; 27: 2820-2828.
22. Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D, Ocherashvilli A, Holbova R, Yosef O, Barbash IM, Leor J,. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007; 116: I-38-I-45.
23. Poncelet AJ, Vercruysse J, Saliez A, Gianello P,. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007; 83: 783-790.
24. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, Harris IR, Popma, SH, Sachs DH, Huang CA,. Immunogenicity of umbilical cord tissue-derived cells. Blood 2008; 111: 430-438.
25. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, Martinoli E, Carlo E, Balconi G, Fiordaliso F, Chimenti S, Cusella G, Dejana E, Cossu G, Latini R,. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infracted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 692-697.
26. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J,. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infracted myocardium: feasibility, cell migration, and body distribution. Circulation 2003; 108: 863-868.
27. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL,. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27: 1114-1122.
28. Driehuys B, Nouls J, Badea A, Bucholz E, Ghaghada K, Petiet A, Hedlund LW,. Small animal imaging with magnetic resonance microscopy. ILAR J. 2008; 49: 35-53.
29. Driehuys B, Hedlund LW,. Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxiol Pathol 2007; 35: 49-58.
30. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, Janes SM,. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009; 69: 8862-8867.
31. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, Mynhier M, Miller RG,. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 1994; 4: 59-64.
32. Phoenix J, Betal D, Roberts N, Helliwell T, Edwards R,. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996; 19: 302-310.
33. Walter G, Cordier L, Bloy D, Sweeney HL,. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 2005; 54: 1369-1376.
34. Gaedigk R, Law DJ, Fitzgerald-Gustafson KM, McNulty SG, Nsumu NN, Modrcin AC, Rinaldi RJ, Pinson D, Fowler SC, Bilgen M, Burns J, Hauschka SD, White RA,. Improvement in survival and muscle function in an mdx/utrn-/- double mutant mouse using a human retinal dystrophin transgene. Neuromuscular Disord 2006; 16: 192-203.
35. McIntosh LM, Baker RE, Anderson JE,. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 1998; 76: 532-541.